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Background: Mitochondrial dynamics are important for glucose-stimulated insulin
secretion in pancreatic beta cells. The mitochondrial elongation factor MiD51 has
been proposed to act as an anchor that recruits Drp1 from the cytosol to the outer
mitochondrial membrane. Whether MiD51 promotes mitochondrial fusion by inactivation
of Drp1 is a controversial issue. Since both the underlying mechanism and the effects
on mitochondrial function remain unknown, this study was conducted to investigate the
role of MiD51 in beta cells.
Methods: Overexpression and downregulation of MiD51 in mouse insulinoma 6
(MIN6) and mouse islet cells was achieved using the pcDNA expression vector and
specific siRNA, respectively. Expression of genes regulating mitochondrial dynamics
and autophagy was analyzed by quantitative Real-Time PCR, glucose-stimulated insulin
secretion by ELISA, and cellular oxygen consumption rate by optode sensor technology.
Mitochondrial membrane potential and morphology were visualized after TMRE and
MitoTracker Green staining, respectively. Immunofluorescence analyses were examined
by confocal microscopy.
Results: MiD51 is expressed in insulin-positive mouse and human pancreatic islet
and MIN6 cells. Overexpression of MiD51 resulted in mitochondrial fragmentation and
cluster formation in MIN6 cells. Mitochondrial membrane potential, glucose-induced
oxygen consumption rate and glucose-stimulated insulin secretion were reduced in MIN6
cells with high MiD51 expression. LC3 expression remained unchanged. Downregulation
of MiD51 resulted in inhomogeneity of the mitochondrial network in MIN6 cells
with hyperelongated and fragmented mitochondria. Mitochondrial membrane potential,
maximal and glucose-induced oxygen consumption rate and insulin secretion were
diminished in MIN6 cells with low MiD51 expression. Furthermore, reduced Mfn2 and
Parkin expression was observed. Based on MiD51 overexpression and downregulation,
changes in the mitochondrial network structure similar to those in MIN6 cells were also
observed in mouse islet cells.
Conclusion: We have demonstrated that MiD51 plays a pivotal role in regulating
mitochondrial function and hence insulin secretion in MIN6 cells. We propose that
this anchor protein of Drp1 is important to maintain a homogeneous mitochondrial
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network and to avoid morphologies such as hyperelongation and clustering which are
inaccessible for degradation by autophagy. Assuming that insulin granule degradation
frequently suppresses autophagy in beta cells, MiD51 could be a key element maintaining
mitochondrial health.
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INTRODUCTION
Mitochondria are highly dynamic organelles that constantly
move in living cells and undergo fusion and fission events
(1–4). Continuous adaptation of the mitochondrial network
morphology is pivotal to maintain the physiological cell
response. Dysfunction of mitochondrial dynamics is proposed
to contribute to several diseases (5–8) and has also been shown
to be involved in the pathogenesis of type 2 diabetes mellitus
(9–13). Fission is vital to recover mitochondrial health by
counteracting organelle hyperfusion and by opening up damaged
mitochondrial areas to degradation (4, 14–16).
The recruitment of dynamin-related protein 1 (Drp1) from
the cytoplasm to the outer mitochondrial membrane and
subsequent oligomerization is the essential initial step for
fission (17–21). Unlike dynamin, Drp1 does not contain a
transmembrane domain and thus relies on anchor proteins
to constrict and eventually split a mitochondrion (22). In
mammalian cells different receptors located in the outer
mitochondrial membrane—in particular fission protein 1 (Fis1)
and mitochondrial fission factor (Mff)—have been proposed
to act in Drp1 recruitment (22). However, the so-called
mitochondrial elongation factors MiD49 and MiD51 (17–21)
are also likely to be involved in the process. Several studies
have postulated that MiD51 interacts with both Drp1 and Mff,
thereby serving as an adaptor to form a trimeric Drp1-MiD-
Mff complex (23–28). It has been suggested that MiD51 acts
as a negative regulator of mitochondrial fission by suppressing
Drp1 function and supports mitochondrial elongation (22, 29,
30). Another recent publication describes MiD51 as a positive
regulator of fission and points out that dimerization of the
protein is required for mitochondrial dynamics regulation
(31). Investigations have not yet been conducted to establish
whether MiD51 is expressed in pancreatic beta cells and impacts
mitochondrial quality control.
While fission is the integral driver of the continuous
mitochondrial network dynamics that ensure metabolic activity,
both fusion, and mitophagy are additionally important to
Abbreviations: Cy5, Cyanine 5 dye; Drp1, Dynamin-related protein 1; FCCP,
Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone; Fis1, Fission protein
1; GTP, Guanosine triphosphatase; LC3, Light chain 3; MAP1, Microtubule-
associated protein 1; Mff, Mitochondrial fission factor; Mfn1, Mitofusin 1;
Mfn2, Mitofusin 2; MiD49, Mitochondrial dynamics protein of 49 kDa;
MiD51, Mitochondrial dynamics protein of 51 kDa; MIN6, Mouse insulinoma
6; MTDR, MitoTracker R© Deep Red FM; OPA1, Optic atrophy protein 1;
PINK1, PTEN-induced putative kinase 1; PTEN, Phosphatase and tensin
homolog; PVDF, Polyvinylidene fluoride; RIPA, Radioimmunoprecipitation assay;
TMRE, Tetramethylrhodamine ethyl ester; VDAC1, Voltage-dependent anion-
selective channel.
achieve the necessary balance. Fusion of the outer and inner
mitochondrial membrane is controlled by the GTPases mitofusin
1 and 2 (Mfn1/Mfn2) and optic atrophy 1 (OPA1), respectively,
and high expression and activity of these proteins cause
elongation (14, 32, 33). Mitophagy is a selective way of disposing
of defective mitochondria by autophagy (34). This process
is initiated by accumulation of the (PTEN)-induced putative
kinase (PINK1) and the ubiquitin ligase Parkin on the outer
mitochondrial membrane. Loss of any of these proteins results in
failure of selective removal of damagedmitochondria (15, 35, 36).
However, the final degradation of mitochondria depends on the
formation of autophagosomes, a process that is mainly conducted
by the autophagosome marker microtubule-associated protein 1
(MAP1) light chain 3 (LC3) (37).
Because mitochondrial metabolism plays a pivotal role in
glucose-stimulated insulin secretion, any changes will result in
beta cell overload (38–42). Specifically, accumulation of damaged
and dysfunctional mitochondria in beta cells is associated with
oxidative stress, loss of respiratory control, and apoptosis (39, 43).
In previous work we demonstrated that expression of both Fis1
and Drp1 have to be adapted precisely to maintain pancreatic
beta cell function (44, 45). However, the relationship between
the two proteins is still unclear in mammalian cells. To elucidate
this question, the present study set out to overexpress and
downregulate MiD51 in pancreatic beta cells to gain further
insight into mitochondrial dynamics and the impact of this
mitochondrial adaptor protein on beta cell function.
MATERIALS AND METHODS
Cell Culture and Primary Pancreatic Islets
Mouse insulinoma 6 (MIN6) cells were cultured in DMEMmedia
containing 25 mmol/l glucose supplemented with 10% fetal
bovine serum and 5% penicillin/streptomycin in a humidified
atmosphere at 37◦C and 5% CO2. Mouse pancreatic islets were
isolated from 12-week-old male NMRI mice by collagenase P
(Roche Diagnostics, Mannheim, Germany) digestion and Ficoll
gradient purification (Ficoll PM 400; Sigma, Seelze, Germany).
This procedure was conducted in accordance with the German
Animal Welfare Act 2006 (last amended 2014) and was approved
by the State Department of Agriculture, Food Safety and
Fisheries, Mecklenburg-Vorpommern (LALLF M-V). Mice were
housed at the central animal care facility of the Medical Faculty,
University of Rostock, receiving conventional rodent chow and
water ad libitum. Human adult pancreatic islets were donated
from biopsies performed during pancreatic surgery, as approved
by the ethics committee of University Medicine Greifswald (BB
050/13). Primary islets were seeded and expanded on x-well
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Tissue Culture Chambers for confocal microscopy (Sarstedt,
Nümbrecht, Germany), and cultured in RPMI 1640 media
containing 11 mmol/l glucose supplemented with 10% fetal
bovine serum and 5% penicillin/streptomycin, 1 mmol/l sodium
pyruvate, 10 mmol/l HEPES, and 200 mmol/l glutamine in a
humidified atmosphere at 37◦C and 5% CO2.
Overexpression and Silencing of MiD51 in
Pancreatic Beta Cells
Overexpression of MiD51 in MIN6 cells and primary mouse
islet cells was achieved using the expression vector pcDNA3.1.
Cells were transfected with pcDNA3.1(–)MiD51 4xMycHisx6
vector (Plasmid #44598, Addgene, Cambridge, MA) for 48 h
using Effectene Transfection Reagent (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. Empty vector
transfection served as control. MiD51 was downregulated in
MIN6 cells and primary mouse islet cells by specific siRNA
(Thermo Fisher, Waltham, MA, USA). A negative control siRNA
(Thermo Fisher) was used for comparison. Cells were incubated
for 48 h using Interferin transfection reagent (Polyplus, Illkirch-
Graffenstadey, France).
Quantitative Real-Time-PCR
Total RNA samples were prepared using the RNeasy total RNA
isolation kit (Qiagen, Hilden, Germany) and quantified using
a spectrophotometer (ND-2000, PeqLab, Erlangen, Germany).
Reverse Transcription was performed using the Maxima R©
First Strand cDNA Synthesis Kit (Fermentas, St. Leon-
Rot, Germany). Gene expression was analyzed using the
TaqMan Universal PCR Master Mix and the following TaqMan
gene expression assays (Applied Biosystems, Carlsbad, CA,
USA): Mm_00724569_m1 and Hs_01007730_g1 for MiD51,
Mm_00550827_m1 for PINK1, Mm_00450187_m1 for Parkin,
Mm_04225236_g1 for LC3, Mm_01255785_m1 for Mfn2,
Mm_01342903_m1 for Drp1 andMm_01288627_g1 for VDAC1.
RT-PCR reactions were performed in triplicates using the
7900HT Real-Time PCR System (Applied Biosystems, Carlsbad,
CA, USA). The relative expression levels were calculated with
the comparative (2−11Ct) method and normalized to ß-actin
(Mm_02619580_g1 and Hs_01060665_g1) gene expression.
Western Blot Analyses
Cells were extracted using radioimmunoprecipitation assay
(RIPA) lysis buffer (50 mmol/l Tris-HCl pH 7.4, 150 mmol/l
NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS,
1 mmol/l EDTA, protease inhibitors) and centrifuged for
15min at 12.000 g. 30 µg protein were separated by SDS-
PAGE and blotted onto Roti R©Fluoro PVDF membrane (Roth,
Karlsruhe, Germany).Membranes were incubated for 1 h at room
temperature with the following primary antibodies: anti-c-Myc
(1:1,000) and anti-GAPDH (1:1,000) (Santa-Cruz Biotechnology,
Santa Cruz, CA, USA) or anti-MiD51 (1:1,000) (Proteintech,
Rosemont, IL, USA) and anti-beta-actin (1:200) (Santa Cruz).
Immunoreactive bands were visualized using the following
fluorescence-labeled secondary antibodies: IRDye 680 CW,
IRDye 800 CW and analyzed via the Odyssey imaging system.
Densitometry measurements of bands were performed using the
Odyssey infrared imaging system (LI-COR, Lincoln, NE, USA).
Immunohistochemistry
For immunohistochemistry analyses cells were seeded on x-well
Tissue Culture Chambers (Sarstedt, Nümbrecht, Germany) and
transfected for 48 h. Cells were fixed with 4% formaldehyde
for 15min and permeabilized with 0.2% Tween20 for 5min
in phosphate-buffered saline. Cells were stained for 1 h with
the primary antibodies: anti-MiD51 (1:100) (Proteintech),
anti-Tom20 (1:100) (Abcam, Cambridge, UK), anti-insulin
(1:100) (Abcam) and anti-LC3 (1:100) (Sigma). Cy5 or FITC-
coupled secondary antibodies (1:250) were used for visualization
(Molecular Probes Invitrogen, Darmstadt, Germany). Cells were
mounted and counterstained using Roti R©-Mount FluorCare
DAPI (Roth, Karlsruhe, Germany) and analyzed using a Fluoview
FV10i confocal microscope (Olympus, Hamburg, Germany).
Mitochondrial Morphology Staining
5 × 105 MIN6 cells were seeded and grown on glass-bottom
dishes (MatTak Corporation, Ashland, MA, USA) and stained
with 20 nmol/l MitoTracker R© Green FM (Molecular Probes
Invitrogen) for 30min at 37◦C. Mitochondrial morphology was
analyzed using a Fluoview FV10i confocal microscope (Olympus,
Hamburg, Germany).
Quantification of Mitochondrial
Morphology
The mitochondrial network structure visualized by
MitoTracker R© Green or Tom20 immunofluorescence
staining was investigated using Imaris software (Oxford
Instruments/Bitplane, Zurich, Switzerland). Mitochondria
were automatically detected from 3D images by generating
a surface on the fluorescence intensity channel after
background subtraction and the volume for each detected
object (mitochondrion) per cell was quantified. Finally,
the geometric mean and the coefficient of variation of the
mitochondrial volume were calculated using the Prism analysis
program (GraphPad Inc., San Diego, CA, USA). An additional
count was made of large objects >30 times the mean volume,
and these were defined as mitochondrial clusters.
Measurement and Quantification of
Mitochondrial Membrane Potential
5 × 105 MIN6 cells were seeded and grown on glass-bottom
dishes (MatTak Corporation, Ashland, MA, USA). Staining
was performed using 6.2 nmol/l tetramethylrhodamine ethyl
ester perchlorate (TMRE,Molecular Probes Invitrogen Detection
Technologies, Eugene, OR, USA) for 30min at 37◦C. Cells were
analyzed using a Fluoview FV10i confocal microscope (Olympus,
Hamburg, Germany) and the mean mitochondrial intensity after
background correction from z maximum intensity projection
images was calculated per cell (region of interest) using Fluoview
software (Olympus).
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Glucose-Stimulated Insulin Secretion
MIN6 and mouse islet cells were incubated for 1 h
in bicarbonate-buffered Krebs-Ringer solution without
glucose, supplemented with 0.1% albumin. Subsequently,
cells were incubated for 1 h in Krebs-Ringer solution
containing 5.5 and 25 mmol/l glucose. Finally, the
incubation buffer from each well was collected and gently
centrifuged to remove detached cells. Secreted insulin
in the supernatant and insulin content was measured in
homogenized scraped cells by ELISA (Mercodia, Uppsala,
Sweden). Protein content was analyzed by Bradford
protein measurement.
Oxygen Consumption Rate
Oxygen consumption was measured 24 h after transfection
using an optode sensor technology-based system (Unisense,
Aarhus, Denmark). 2 × 106 MIN6 cells were incubated
for 1 h in bicarbonate-buffered Krebs-Ringer solution
without glucose. Subsequently, cells were incubated for 1 h
in Krebs-Ringer solution containing 25 mmol/l glucose
and stimulated respiration was measured over 10min.
Thereafter, 1µM oligomycin was added and the proton
leak was determined for the next 10min. Finally, 5µM FCCP
was added and maximal respiration was measured for the
last 10 min.
Cell Viability Assay
AlamarBlue R© cell viability reagent (Thermo Fisher Scientific,
Waltham, MA, USA) was used according to the manufacturer’s
instructions. The resulting fluorescence was analyzed at 530 nm
with the VICTOR3TM Multilabel Counter (Perkin Elmer,
Waltham, MA, USA).
Statistical Analysis
Data are expressed as mean ± SEM. Statistical analyses were
performed by unpaired Student’s t test or ANOVA followed by
Bonferroni’s test using the Prism analysis program (GraphPad
Inc.). Statistical significance is expressed as ∗p< 0.05, ∗∗p< 0.01,
∗∗∗p< 0.001.
RESULTS
Expression of MiD51 in Beta Cells and
Pancreatic Islets
MiD51 expression was demonstrated in MIN6 cells and in
primary mouse and adult human islets (Figure 1). The mRNA
expression level of MiD51 was higher in the clonal insulin-
secreting MIN6 cells (Figure 1A) than in primary mouse and
human islets (Figures 1B,C); this finding was independent
of glucose concentration. Immunofluorescence staining and
subsequent confocal microscopy confirmed MiD51 protein
expression in MIN6 cells (Figure 1A), primary mouse islet cells
(Figure 1B) and human islet cells (Figure 1C) that were insulin-
positive (Figure 1D).
Enhanced and Reduced Gene and Protein
Expression of MiD51 in MIN6 Cells
MiD51 overexpression was confirmed at the gene (Figure 2A)
and protein (Figures 2B,D,E) level. Immunofluorescence
analyses additionally demonstrated the significant difference
between endogenous and enhanced levels of MiD51 in
MIN6 cells (Figure 2C). Furthermore, significant MiD51
downregulation was demonstrated at the gene (Figure 2F) and
protein level, both by immunofluorescence staining (Figure 2G)
and western blot analyses (Figures 2H,I) compared with negative
control transfected cells.
Overexpression and Downregulation of
MiD51 Results in Mitochondrial Network
Inhomogeneity in MIN6 and Mouse Islet
Cells
Control transfected MIN6 cells (Figures 3A,B top) displayed
homogeneous distribution of mitochondria, whereas clustered
as well as fragmented mitochondria were present in MiD51-
overexpressing MIN6 cells (Figures 3A,B bottom). In MIN6
cells with reduced MiD51 expression (Figures 3C,D bottom)
hyperelongated and fragmented mitochondria were detectable
compared with control siRNA transfected cells (Figures 3C,D
top). In addition, the mitochondrial network was described
by volume analysis (Figures 3E,F). Both, overexpression and
downregulation of MiD51 resulted in a significantly higher
fragmentation rate (reduced mean mitochondrial volume, left).
However, whereas overexpression evoked mitochondrial cluster
formation (middle), downregulation caused significantly greater
network inhomogeneity (higher coefficient of variation, right)
compared with control cells. Altogether comparable results
were observed by mitochondrial detection via MitoTracker R©
Green staining of living MIN6 cells (Figures 3A,C,E) and
Tom20 immunofluorescence (Figures 3B,D,F) staining
of fixed MIN6 cells. Similar findings were observed by
investigations of primary mouse islets cultured on x-well
Tissue Culture Chambers at the single (insulin-positive) cell
level. Mitochondrial cluster formation was detectable after
MiD51 overexpression (Figure 4B) compared with control
cells (Figures 4A,C) and MiD51 downregulation mainly
resulted in fragmentation (Figure 4D). MiD51 expression
calculated from immunofluorescence images was increased
by 48 ± 17 % after overexpression and reduced by 35 ± 19%
after downregulation.
Overexpression and Downregulation of
MiD51 Changes Mitochondrial Membrane
Potential and Oxygen Consumption in
MIN6 Cells
Mitochondrial membrane potential was significantly reduced
by 28% in MIN6 cells overexpressing MiD51 compared
with control transfected cells (Figure 5A). Mitochondrial
membrane potential in MIN6 cells with downregulated
MiD51 expression was significantly reduced by 33%
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FIGURE 1 | MiD51 expression in MIN6 and primary beta cells. Endogenous MiD51 protein expression is demonstrated in MIN6 (A, left), primary mouse islet (B, left)
and primary human islet (C, left) cells with by immunofluorescence. In addition, staining of primary human islet cells with insulin and MiD51 antibodies is shown (D).
Representative images from three independent experiments are shown. Scale bar: 10µm. Endogenous MiD51 gene expression is shown in MIN6 (A, right) and
primary mouse islet (B, right) cells after incubation with 5.5 (white bars) and 25 mmol/l glucose (black bars), and in human islet cells after incubation with 11 mmol/l
glucose (black bar) (C, right) for 48 h.
(Figure 5B). Oxygen consumption rates were also changed
accordingly (Figure 6). MiD51-overexpressing MIN6 cells
showed significantly lower respiration after stimulation
with 25 mmol/l glucose and the proton leak after addition
of 1µM oligomycin was slightly reduced (Figure 6A).
Maximal respiration after uncoupling with 5µM FCCP
Frontiers in Endocrinology | www.frontiersin.org 5 April 2020 | Volume 11 | Article 232
Schultz et al. MiD51 in Pancreatic Beta Cells
FIGURE 2 | Overexpression and downregulation of MiD51 in MIN6 cells. Gene expression (A,F) of MiD51 in pcDNA-MiD51 transfected (A, black bar) and si MiD51
transfected (F, gray bar) compared with corresponding control transfected (white bars) MIN6 cells. Data are expressed as mean ± SEM from six independent
experiments; ***p < 0.001 (Student’s t-test). MiD51 protein overexpression was analyzed by western blotting using an antibody against the c-Myc tag (B).
Immunofluorescence analyses were performed with an antibody against MiD51 (C,G). Representative images from six independent experiments are shown. Scale
bar: 10µm (C,G). Protein expression (D–I) of MiD51 in pcDNA-MiD51 transfected (D,E, black and striped bar) and si MiD51 transfected (H, I, gray bar) compared
with corresponding control transfected (white bars) MIN6 cells. Representative western blots are shown (D,I). Note that the size of overexpressed MiD51 is increased
due to the c-Myc tag (B,D,E, striped bar). Data (D,H) are expressed as mean ± SEM from four independent experiments; ***p < 0.001 (Student’s t-test).
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FIGURE 3 | Mitochondrial morphology after overexpression and downregulation of MiD51 in MIN6 cells. MIN6 cells (transfected as indicated) were analyzed by
confocal microscopy after staining with MitoTracker® Green (A,C) or immunofluorescence staining with Tom20 (B,D). Representative images from three independent
experiments each are shown. Scale bar: 10µm. The mitochondrial structure visualized by MitoTracker® Green staining (E) or Tom20 immunofluorescence staining (F)
of at least 20 cells per experiment was automatically analyzed and the mean mitochondrial volume, the number of mitochondrial clusters and the coefficient of
variation of the mitochondrial volume were calculated. Data are expressed as mean ± SEM in % of controls (white bar) for pcDNA-MiD51 transfected (black bars) and
si MiD51 transfected (gray bars) cells. *p < 0.05, **p < 0.01, **p < 0.001 (ANOVA/Bonferroni’s test).
was unchanged (Figure 6A). However, MIN6 cells with reduced
MiD51 expression exhibited significantly lower respiration
both after stimulation with 25 mmol/l glucose and after
uncoupling with 5µM FCCP (Figure 6B). The proton leak
after addition of 1µM oligomycin was again slightly reduced
(Figure 6B).
Overexpression of MiD51 Reduces
Glucose-Stimulated Insulin Secretion in
MIN6 and Mouse Islet Cells
Control transfected MIN6 cells showed a significant 2.0-fold
increase in insulin secretion after stimulation with 25 mmol/l
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FIGURE 4 | Mitochondrial morphology after overexpression and downregulation of MiD51 in primary mouse islet cells. Primary mouse islets were cultured on x-well
Tissue Culture Chambers and transfected with pcDNA (A), pcDNA-MiD51 (B), si control (C), or si MiD51 (D). Finally, cells were analyzed by confocal microscopy after
immunofluorescence staining with Tom20 and insulin antibodies or MiD51 antibody (bottom). Changes in mitochondrial morphology are best detectable in transfected
outspread mouse islets (middle), but are also visible in whole islets (top). Representative images from three independent experiments each are shown. Scale bar:
10µm.
glucose compared with 5.5 mmol/l glucose (Figure 7A).
Overexpression of MiD51 resulted in a significant loss
of glucose-stimulated insulin secretion (Figure 7A). This
finding was similar in primary mouse islet cells: after control
transfection there was a 4.7-fold increase in insulin secretion
after stimulation with 25 mmol/l glucose compared with
5.5 mmol/l glucose (Figure 7B). However, overexpression of
MiD51 resulted not only in total glucose unresponsiveness
but also in doubling of the basal insulin secretion rate in
mouse islet cells (Figure 7B). MIN6 cells transfected with
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FIGURE 5 | Reduced mitochondrial membrane potential in MIN6 cells after overexpression and downregulation of MiD51. Mitochondrial membrane potential was
investigated in MIN6 cells using TMRE staining after transfection with (A) pcDNA (white bar) or pcDNA-MiD51 (black bar) and (B) si control (white bar) or si MiD51
(gray bar). Data are expressed as mean ± SEM from six independent experiments; **p < 0.01, ***p < 0.001 (Student’s t-test). Representative confocal microscopy
images are shown in addition. Scale bar: 10µm.
negative control siRNA also exhibited a significant 2.0-fold
increase in insulin secretion after stimulation with 25 mmol/l
glucose compared with 5.5 mmol/l glucose (Figure 7C).
Downregulation of MiD51 resulted in a significant reduction in
insulin secretion after stimulation with 25 mmol/l glucose
compared with 5.5 mmol/l glucose. A similar finding
was observed in primary mouse islet cells: after control
transfection there was a 3-fold increase in insulin secretion
after stimulation with 25 mmol/l glucose compared with 5.5
mmol/l glucose, and this was reduced to 2-fold after MiD51
downregulation (Figure 7D).
Effect of MiD51 Expression on Mitophagy,
Mitochondrial Function, and Viability
Mitophagy is a cellular process of autophagy-based
mitochondrial degradation that eliminates dysfunctional
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FIGURE 6 | Overexpression and downregulation of MiD51 changes the
oxygen consumption rate in MIN6 cells. Oxygen consumption was measured
under the experimental conditions indicated in MIN6 cells after transfection
with (A) pcDNA (white bars) or pcDNA-MiD51 (black bars) and (B) si control
(white bars) or si MiD51 (gray bars). Data are expressed as mean ± SEM from
six to eight independent experiments; **p < 0.01 (ANOVA/Bonferroni’s test).
mitochondria. To investigate the effect of MiD51 expression
level on mitochondrial clearance we measured gene and
protein expression of the key autophagy marker LC3 and
gene expression of the specific mitochondrial degradation
signaling proteins PINK1 and Parkin in transfected MIN6
cells. All remained unchanged after MiD51 overexpression
(Figures 8A,E,F). In contrast, Parkin expression was
significantly reduced after MiD51 downregulation,
whereas no significant changes were observed for LC3
and PINK1 (Figures 8B,E,G). Voltage-dependent anion-
selective channel 1 (VDAC1) expression remained stable in
response to changes in MiD51 expression (Figures 8A,B).
Furthermore, no specific effects on MIN6 cell viability
were observed (Figures 8C,D). mRNA expression of the
fission protein Drp1 is not altered by either high or low
MiD51 expression (Figures 8A,B). The fusion protein
Mfn2 was significantly reduced after downregulation of
MiD51 (Figure 8B) but remained unchanged after MiD51
overexpression (Figure 8A).
DISCUSSION
A healthy mitochondrial network is crucial for metabolic
homeostasis and insulin secretion in pancreatic beta cells.
There is a growing body of evidence to indicate that
alterations in mitochondrial metabolism and dynamics
lead to beta cell dysfunction (9, 39, 46, 47). A key step
in mitochondrial fission is the recruitment of Drp1 to
the mitochondrial outer membrane surface by MiD51,
among other factors (18, 22–24). We have used MiD51
overexpression and downregulation to investigate the effect of
MiD51 on mitochondrial morphology and cellular function in
beta cells.
It has been suggested that MiD51 suppresses Drp1 function,
resulting in mitochondrial elongation (24, 26, 28). However,
other workers have postulated facilitation of Drp1-mediated
fission by MiD51 (18, 31). However, because only Drp1 has
GTPase activity and can separate mitochondria, MiD51 must
act in some way by influencing Drp1. After overexpression
of MiD51 we observed clustering of mitochondria to form
huge aggregates in MIN6 cells, and it is well-known that
mitochondrial cluster formation is evoked by fragmented
mitochondria (48). Because MiD51 acts as a receptor
for recruitment of cytosolic Drp1, we propose that small
mitochondria aggregate at high MiD51 expression. We did
not observe tubular elements in the mitochondrial network
of MIN6 cells after MiD51 overexpression. The situation was
similar in mouse islet cells, where we also found fragmentation
and mitochondrial cluster formation. Downregulation of
MiD51 in MIN6 cells—and similarly in mouse islet cells—
resulted in inhomogeneity of the mitochondrial network,
with hyperelongated mitochondria clearly present alongside
small fragmented mitochondria. In contrast to the unmodified
expression of other fusion and fission proteins at high MiD51
expression, Mfn2—a key regulator of mitochondrial fusion—
was significantly reduced at low MiD51 expression. This
finding in itself might account for fragmentation, but not for
mitochondrial network inhomogeneity and requires further
investigation. In summary, MiD51 seems to be important
for the organization of the mitochondrial network in beta
cells, acting to balance network dynamics rather than as an
elongation or fission factor as such. In addition, our results
strengthen the hypothesis that the concentration of anchor
proteins of Drp1 is precisely regulated in beta cells. We
have previously demonstrated that moderate Fis1 expression
improves glucose-stimulated insulin secretion, whereas high
expression results in loss of glucose responsiveness (45).
Furthermore, only small numbers of mitochondrial aggregates
were present during moderate Fis1 expression, whereas high
Fis1 expression resulted in mitochondrial clustering and
formation of loop-shaped mitochondria. Stepwise modulation
of MiD51 expression together with Drp1 and also Fis1
and Mff in future studies will be crucial to shed light on
this question.
Because of the high demands associated with mitochondrial
respiration during insulin secretion, pancreatic beta cells
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FIGURE 7 | Reduced glucose-stimulated insulin secretion after overexpression and downregulation of MiD51 in MIN6 and primary mouse islet cells. Basal (5.5 mmol/l
glucose, open bars) and stimulated (25 mmol/l glucose, striped bars) insulin secretion in MIN6 (A,C) and primary mouse islet (B,D) cells after transfection with pcDNA
(A,B) or si control (C,D) (white bars) or pcDNA-MiD51 (A,B) or si MiD51 (C,D) (gray bars). Data are expressed as mean ± SEM from six independent experiments; *p
< 0.05, ***p < 0.001 (ANOVA/Bonferroni’s test).
consume large amounts of oxygen. The efficiency with which
oxidative phosphorylation is coupled to ATP synthesis is
important for insulin secretion. Indeed, overexpression of
MiD51 in MIN6 cells reduced the oxygen consumption
rate at stimulatory glucose. Consequently, enhanced MiD51
expression also lowered glucose-stimulated insulin secretion
in MIN6 cells and mouse islet cells. It is noteworthy here
that the maximal oxygen consumption rate and basal insulin
secretion remained unaffected in MIN6 cells. This is consistent
with data suggesting beta cell dysregulation in consequence
of altered mitochondrial dynamics (44, 45). In mouse islet
cells we observed higher basal secretion after enhanced
MiD51 expression. The data here are limited because first
our transfection rate showed high variability and secondly
non-beta cells are also affected by this approach, which
might have modulating effects on glucagon secretion. Other
workers have demonstrated that mitochondrial fragmentation
per se does not affect insulin secretion (41). However, the
degree of mitochondrial network disruption is evidently
crucial for the specific conclusions drawn. It has been
shown that after downregulation of Drp1 in beta cells the
initially homogeneous mitochondrial network becomes
highly heterogeneous with elongated, clustered and looped
mitochondria. These morphological changes were found to
correlate with functional alterations, including mitochondrial
membrane potential, ATP generation and a significant
loss of glucose-stimulated insulin secretion, whereas basal
insulin secretion was also lowered to a lesser extent (44).
In the present study downregulation of MiD51 reduced
both basal and glucose-stimulated insulin secretion and,
in contrast to overexpression, some glucose responsiveness
was retained in mouse islet cells. Accordingly, we observed
reductions in glucose-mediated and maximal respiration,
suggesting impairment of total mitochondrial capacity.
Another recently published study likewise showed that
MiD51 deficiency impaired mitochondrial respiration in HeLa
cells (49).
Mitophagy is an important process for the selective
degradation of damaged mitochondria (35, 50). Mitochondrial
fission appears to be essential for selective mitophagy because, in
order to undergo degradation, dysfunctional mitochondrial
material must be separated from the network (36, 37).
PINK1 accumulates on the outer membrane of damaged
mitochondria and it is usually these mitochondria that undergo
fragmentation (51). Finally, binding of Parkin to PINK1 occurs
as a consequence of the dissipation of membrane potential
and initiates autophagy (35, 50). Although gene expression
of PINK1 and Parkin was not induced after overexpression
of MiD51 in MIN6 cells, mitochondrial membrane potential
in these cells was significantly reduced. We also investigated
the expression of the autophagy marker LC3, and in line
with our PINK1/Parkin results we found no differences in
LC3 expression in MIN6 cells after overexpression of MiD51
compared with control cells. This argues in favor of failed
augmentation of mitophagy in MIN6 cells with enhanced
MiD51 expression, resulting in mitochondrial clustering. This
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FIGURE 8 | Expression and viability of MIN6 cells. Expression of genes that regulate mitophagy (LC3, PINK1 and Parkin), mitochondrial function (VDAC1) or
mitochondrial dynamics (Drp1 and Mfn2) was investigated in MIN6 cells after transfection with (A) pcDNA (white bars) or pcDNA-MiD51 (black bars) and (B) si control
(white bars) or si MiD51 (gray bars). Data are expressed as mean ± SEM from six independent experiments; *p < 0.01, **p < 0.01 (ANOVA/Bonferroni’s test). Viability
(C,D) of MIN6 cells was analyzed using Alamar Blue® after transfection with pcDNA (C) or si control (D) (white bars) or pcDNA-MiD51 (C) or si MiD51 (D) (gray bars)
and without (open bars) or with (striped bars) 10mM H2O2. Data are expressed as mean ± SEM from four independent experiments. MIN6 cells (transfected as
indicated) were analyzed by confocal microscopy after immunofluorescence staining with LC3 (E). Representative images from three independent experiments each
are shown. Scale bar: 10µm. At least 15 cells per experiment were automatically analyzed and the mean LC3 expression was calculated. Data are expressed as
mean ± SEM in % of controls for overexpression (F) and downregulation (G).
hypothesis is consistent with very recently published data
in HeLa cells, demonstrating that overexpression of MiD51
confers resistance to PINK1-Parkin-dependent mitophagy
(49). The same study also provides clear evidence of the
converse: MiD51 depletion facilitates PINK1-Parkin-mediated
mitophagy at least in part by degradation of Mfn2 (49).
After downregulation of MiD51 we found mitochondrial
aggregates, reduced mitochondrial membrane potential and
reduced Parkin and Mfn2 expression, but only slightly increased
LC3 expression. It has been suggested that cells unable to
remove clustered mitochondria by mitophagy undergo caspase-
mediated apoptosis (48). Furthermore, it has been postulated
that loss of MiD51 confers susceptibility to BAX-mediated
cell death (49). We did not detect reduced cell viability after
overexpression and downregulation of MiD51 in MIN6 cells.
This suggests that feedback mechanisms in MIN6 cells differ
from those in HeLa cells and fibroblasts, possibly accounting
for the absence of mitophagy. There is mounting evidence
that autophagy in beta cells is regulated differently: lysosomal
degradation of insulin granules suppresses the process (52),
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thus exerting a definite impact on mitophagy. Future studies
of the effect of MiD51 in primary beta cells are needed to test
these hypotheses.
In summary, we have shown that MiD51 is expressed
in mouse and human pancreatic insulin- positive islet
cells. High expression of MiD51 resulted in mitochondrial
fragmentation and cluster formation. We postulate abnormally
high recruitment of active Drp1 to the outer mitochondrial
membrane due to MiD51 accumulation and dimerization
(31). It must be borne in mind that cytosolic Drp1 is
accessible for different regulatory mechanisms, namely
inhibition by ubiquitination and phosphorylation, whereas
this is not the case for mitochondrially anchored Drp1 in
the oligomeric state (22). Under such conditions, PINK1
cannot bind to the outer mitochondrial membrane and
initiate mitophagy, and complexes may develop between
fragmented mitochondria, thus supporting mitochondrial
cluster formation. Low ATP generation from the resulting
mitochondrial network significantly reduces insulin secretion,
and the residual aged insulin granules undergo lysosomal
degradation (52) that will suppress autophagy and hence
mitophagy. Both the overexpression and downregulation
of MiD51 further support the hypothesis that regulation
of mitochondrial fission plays a key role in maintaining
insulin secretion in pancreatic beta cells. Low expression
of MiD51 resulted in inhomogeneity of the mitochondrial
network in beta cells, mediated at least in part by suppression
of Mfn2 and Parkin. To understand the specific feedback
loops that adjust the expression of Drp1 anchor proteins on
the outer mitochondrial membrane—namely MiD51, Fis1
and Mff—there is a pressing need for continuing work in
pancreatic beta cells from healthy subjects and people with type
2 diabetes.
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